Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Analytical validation of a next generation sequencing liquid biopsy assay for high sensitivity broad molecular profiling.

Plagnol V, Woodhouse S, Howarth K, Lensing S, Smith M, Epstein M, Madi M, Smalley S, Leroy C, Hinton J, de Kievit F, Musgrave-Brown E, Herd C, Baker-Neblett K, Brennan W, Dimitrov P, Campbell N, Morris C, Rosenfeld N, Clark J, Gale D, Platt J, Calaway J, Jones G, Forshew T.

PLoS One. 2018 Mar 15;13(3):e0193802. doi: 10.1371/journal.pone.0193802. eCollection 2018.

2.

Non-blood circulating tumor DNA detection in cancer.

Peng M, Chen C, Hulbert A, Brock MV, Yu F.

Oncotarget. 2017 Aug 4;8(40):69162-69173. doi: 10.18632/oncotarget.19942. eCollection 2017 Sep 15. Review.

3.

Analysis of significantly mutated genes as a clinical tool for the diagnosis in a case of lung cancer.

Miyashita Y, Hirotsu Y, Tsutsui T, Higashi S, Sogami Y, Kakizaki Y, Goto T, Amemiya K, Oyama T, Omata M.

Respir Med Case Rep. 2017 Feb 17;20:171-175. doi: 10.1016/j.rmcr.2017.02.008. eCollection 2017.

4.

Early Detection of Lung Cancer with Meso Tetra (4-Carboxyphenyl) Porphyrin-Labeled Sputum.

Patriquin L, Merrick DT, Hill D, Holcomb RG, Lemieux ME, Bennett G, Karia B, Rebel VI, Bauer T 2nd.

J Thorac Oncol. 2015 Sep;10(9):1311-1318. doi: 10.1097/JTO.0000000000000627.

5.

Updates and controversies in the rapidly evolving field of lung cancer screening, early detection, and chemoprevention.

Kathuria H, Gesthalter Y, Spira A, Brody JS, Steiling K.

Cancers (Basel). 2014 May 16;6(2):1157-79. doi: 10.3390/cancers6021157.

6.

Circulating DNA: diagnostic tool and predictive marker for overall survival of NSCLC patients.

Catarino R, Coelho A, Ara├║jo A, Gomes M, Nogueira A, Lopes C, Medeiros R.

PLoS One. 2012;7(6):e38559. doi: 10.1371/journal.pone.0038559. Epub 2012 Jun 12.

7.

Benefits and harms of CT screening for lung cancer: a systematic review.

Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, Byers T, Colditz GA, Gould MK, Jett JR, Sabichi AL, Smith-Bindman R, Wood DE, Qaseem A, Detterbeck FC.

JAMA. 2012 Jun 13;307(22):2418-29. doi: 10.1001/jama.2012.5521. Review. Erratum in: JAMA. 2013 Jun 5;309(21):2212. JAMA. 2012 Oct 3;308(13):1324.

8.

Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis.

Rivlin N, Brosh R, Oren M, Rotter V.

Genes Cancer. 2011 Apr;2(4):466-74. doi: 10.1177/1947601911408889.

9.

Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers.

Yu L, Todd NW, Xing L, Xie Y, Zhang H, Liu Z, Fang H, Zhang J, Katz RL, Jiang F.

Int J Cancer. 2010 Dec 15;127(12):2870-8. doi: 10.1002/ijc.25289.

10.
11.

Molecular recognition of small-cell lung cancer cells using aptamers.

Chen HW, Medley CD, Sefah K, Shangguan D, Tang Z, Meng L, Smith JE, Tan W.

ChemMedChem. 2008 Jun;3(6):991-1001. doi: 10.1002/cmdc.200800030.

12.

Sputum examination for early detection of lung cancer.

Thunnissen FB.

J Clin Pathol. 2003 Nov;56(11):805-10. Review.

14.
15.

Lung cancer. 1: prevention of lung cancer.

Goodman GE.

Thorax. 2002 Nov;57(11):994-9. Review.

16.

Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening.

El-Naggar AK, Mao L, Staerkel G, Coombes MM, Tucker SL, Luna MA, Clayman GL, Lippman S, Goepfert H.

J Mol Diagn. 2001 Nov;3(4):164-70.

17.

Early glandular neoplasia of the lung.

Westra WH.

Respir Res. 2000;1(3):163-9. Epub 2000 Nov 17. Review.

18.

Early detection for lung cancer. New tools for casefinding.

Lam S, Lam B, Petty TL.

Can Fam Physician. 2001 Mar;47:537-44. Review.

19.

Detection of early lung cancer.

Porter JC, Spiro SG.

Thorax. 2000 Aug;55 Suppl 1:S56-62. Review. No abstract available.

20.

Molecular detection of tumour DNA in serum and peritoneal fluid from ovarian cancer patients.

Hickey KP, Boyle KP, Jepps HM, Andrew AC, Buxton EJ, Burns PA.

Br J Cancer. 1999 Aug;80(11):1803-8.

Supplemental Content

Support Center